drugset
drugset / Trial / NCT00709332

A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.

NCT00709332 ↗

Phase 1 Completed 47 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of the study is to assess the effect of folic acid administration on the blood level and the breakdown products of oral contraceptive (OC) \[250 mcg NGM/35 mcg EE\] tablets.

Timeline

Start
2005-01
Primary completion
—
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Norgestimate Small molecule 250 ug Oral
Subject ethinyl estradiol Small molecule 35 ug Oral
Subject folic acid Other / unclassified 1 mg Oral

Indications

No indication recorded.